DJ MARKET TALK: Credit Suisse Ups Actelion Target To CHF250

11/21/06 - Dow Jones Newswires

0852 GMT [Dow Jones] Credit Suisse lifts the price target for Actelion (ATLN.EB) to CHF250 from CHF225 after company's recent acquisition of CoTherix (CTRX). Expects a boost from sales of CoTherix's key drug Ventavis. Says the deal will be earnings accretive in '08 and will boost net profit by 6% in that year. Shares trade +0.6% at CHF216.2. (GOM)

 
Contact us in London. +44-20-7842-9464 
Markettalk.eu@dowjones.com 
 
 

(END) Dow Jones Newswires

November 21, 2006 03:52 ET (08:52 GMT)

Copyright (c) 2006 Dow Jones & Company, Inc.